Pathological Aspects of Cholangiocarcinoma

Overview

Journal HPB (Oxford)

Publisher Elsevier

Specialty Gastroenterology

Date 2008 Sep 6

PMID 18773061

Citations 10

Authors

I Esposito

P Schirmacher

Affiliations

Soon will be listed here.

Abstract

Cholangiocarcinoma (CC) arises from the biliary epithelium and in most cases represents adenocarcinoma. Pathomorphological evaluation is of decisive impact for the prognosis and management of CC. Morphological subtyping (histotype; hilar vs peripheral type), TNM classification, lymphatic spread, and resection margin status are of prognostic relevance. Distinction from hepatic metastases may be aided by immunohistology and clinico-pathological correlation. There is convincing evidence of the development of CC via premalignant lesions, especially biliary intraepithelial neoplasia, although further knowledge about the biology and diagnostic definition of these lesions has to be accumulated. Currently, there are no established molecular markers of prognosis or therapeutic target structures to be evaluated at the tissue level. Future progress is needed and expected in novel differential diagnostic and predictive markers, in uniform definition of resection margin status and further understanding of molecular and morphological changes in the development of CC.

Citing Articles

British Society of Gastroenterology guidelines for the diagnosis and management of cholangiocarcinoma.

Rushbrook S, Kendall T, Zen Y, Albazaz R, Manoharan P, Pereira S Gut. 2023; 73(1):16-46.

PMID: 37770126 PMC: 10715509. DOI: 10.1136/gutjnl-2023-330029.

A Cholangioblastic Variant of Cholangiocarcinoma.

Verhoeff K, Bacani J, Fung C, Canterbury L ACG Case Rep J. 2022; 9(2):e00746.

PMID: 35187186 PMC: 8849266. DOI: 10.14309/crj.0000000000000746.

Genetic Screens Identify a Context-Specific PI3K/p27Kip1 Node Driving Extrahepatic Biliary Cancer.

Falcomata C, Barthel S, Ulrich A, Diersch S, Veltkamp C, Rad L Cancer Discov. 2021; 11(12):3158-3177.

PMID: 34282029 PMC: 7612573. DOI: 10.1158/2159-8290.CD-21-0209.

Novel Potential Biomarkers for Infection and Associated Cholangiocarcinoma.

Aksorn N, Roytrakul S, Kittisenachai S, Leelawat K, Chanvorachote P, Topanurak S In Vivo. 2018; 32(4):871-878.

PMID: 29936472 PMC: 6117776. DOI: 10.21873/invivo.11321.

Interactive role of diabetes mellitus and female sex in the risk of cholangiocarcinoma: A population-based nested case-control study.

Huang Y, Wu A, Chiou H, Chuang M, Meng T, Chien L Oncotarget. 2016; 8(4):6642-6651.

PMID: 28036262 PMC: 5351659. DOI: 10.18632/oncotarget.14254.

References

Nakeeb A, Pitt H, Sohn T, Coleman J, Abrams R, Piantadosi S . Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg. 1996; 224(4):463-73; discussion 473-5. PMC: 1235406. DOI: 10.1097/00000658-199610000-00005. View

Wakai T, Shirai Y, Moroda T, Yokoyama N, Hatakeyama K . Impact of ductal resection margin status on long-term survival in patients undergoing resection for extrahepatic cholangiocarcinoma. Cancer. 2005; 103(6):1210-6. DOI: 10.1002/cncr.20906. View

Kayahara M, Nagakawa T, Ueno K, Ohta T, Takeda T, Miyazaki I . Lymphatic flow in carcinoma of the distal bile duct based on a clinicopathologic study. Cancer. 1993; 72(7):2112-7. DOI: 10.1002/1097-0142(19931001)72:7<2112::aid-cncr2820720709>3.0.co;2-x. View

Maeda T, Takenaka K, Taguchi K, Kajiyama K, Shirabe K, Shimada M . Adenosquamous carcinoma of the liver: clinicopathologic characteristics and cytokeratin profile. Cancer. 1997; 80(3):364-71. View

Sasaki A, Aramaki M, Kawano K, Morii Y, Nakashima K, Yoshida T . Intrahepatic peripheral cholangiocarcinoma: mode of spread and choice of surgical treatment. Br J Surg. 1998; 85(9):1206-9. DOI: 10.1046/j.1365-2168.1998.00815.x. View

Minervini M, Demetris A, Lee R, Carr B, Madariaga J, Nalesnik M . Utilization of hepatocyte-specific antibody in the immunocytochemical evaluation of liver tumors. Mod Pathol. 1997; 10(7):686-92. View

Pliskin A, Cualing H, Stenger R . Primary squamous cell carcinoma originating in congenital cysts of the liver. Report of a case and review of the literature. Arch Pathol Lab Med. 1992; 116(1):105-7. View

Suzuki S, Sakaguchi T, Yokoi Y, Okamoto K, Kurachi K, Tsuchiya Y . Clinicopathological prognostic factors and impact of surgical treatment of mass-forming intrahepatic cholangiocarcinoma. World J Surg. 2002; 26(6):687-93. DOI: 10.1007/s00268-001-0291-1. View

Abdul-Al H, Makhlouf H, Goodman Z . Expression of estrogen and progesterone receptors and inhibin-alpha in hepatobiliary cystadenoma: an immunohistochemical study. Virchows Arch. 2007; 450(6):691-7. DOI: 10.1007/s00428-007-0411-x. View

10.

Jarnagin W, Fong Y, DeMatteo R, Gonen M, BURKE E, Bodniewicz BS J . Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg. 2001; 234(4):507-17; discussion 517-9. PMC: 1422074. DOI: 10.1097/00000658-200110000-00010. View

11.

Aishima S, Kuroda Y, Nishihara Y, Iguchi T, Taguchi K, Taketomi A . Proposal of progression model for intrahepatic cholangiocarcinoma: clinicopathologic differences between hilar type and peripheral type. Am J Surg Pathol. 2007; 31(7):1059-67. DOI: 10.1097/PAS.0b013e31802b34b6. View

12.

DeOliveira M, Cunningham S, Cameron J, Kamangar F, Winter J, Lillemoe K . Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg. 2007; 245(5):755-62. PMC: 1877058. DOI: 10.1097/01.sla.0000251366.62632.d3. View

13.

Nakajima T, Tajima Y, Sugano I, Nagao K, Kondo Y, Wada K . Intrahepatic cholangiocarcinoma with sarcomatous change. Clinicopathologic and immunohistochemical evaluation of seven cases. Cancer. 1993; 72(6):1872-7. DOI: 10.1002/1097-0142(19930915)72:6<1872::aid-cncr2820720614>3.0.co;2-n. View

14.

Ogura Y, Takahashi K, Tabata M, Mizumoto R . Clinicopathological study on carcinoma of the extrahepatic bile duct with special focus on cancer invasion on the surgical margins. World J Surg. 1994; 18(5):778-84. DOI: 10.1007/BF00298931. View

15.

Zen Y, Adsay N, Bardadin K, Colombari R, Ferrell L, Haga H . Biliary intraepithelial neoplasia: an international interobserver agreement study and proposal for diagnostic criteria. Mod Pathol. 2007; 20(6):701-9. DOI: 10.1038/modpathol.3800788. View

16.

Devaney K, Goodman Z, Ishak K . Hepatobiliary cystadenoma and cystadenocarcinoma. A light microscopic and immunohistochemical study of 70 patients. Am J Surg Pathol. 1994; 18(11):1078-91. View

17.

Okuda K, Kubo Y, Okazaki N, Arishima T, Hashimoto M . Clinical aspects of intrahepatic bile duct carcinoma including hilar carcinoma: a study of 57 autopsy-proven cases. Cancer. 1977; 39(1):232-46. DOI: 10.1002/1097-0142(197701)39:1<232::aid-cncr2820390137>3.0.co;2-y. View

18.

Hanazaki K, Kajikawa S, Shimozawa N, Shimada K, Hiraguri M, Koide N . Prognostic factors of intrahepatic cholangiocarcinoma after hepatic resection: univariate and multivariate analysis. Hepatogastroenterology. 2002; 49(44):311-6. View

19.

Isa T, Kusano T, Muto Y, Furukawa M, Kiyuna M, Toda T . Clinicopathologic features of resected primary adenosquamous carcinomas of the liver. J Clin Gastroenterol. 1998; 25(4):623-7. DOI: 10.1097/00004836-199712000-00015. View

20.

Yamaguchi K, Chijiiwa K, Saiki S, Shimizu S, Takashima M, Tanaka M . Carcinoma of the extrahepatic bile duct: mode of spread and its prognostic implications. Hepatogastroenterology. 1997; 44(17):1256-61. View